St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
Explore some of the remarkable achievements of St. Jude investigators, which reflect our dedication to pioneering research, innovative treatments, and the pursuit to advance knowledge and improve outcomes for children battling cancer and other catastrophic diseases.
AAAS, the world's largest general scientific society recognized Chi for his contributions to immunometabolism.
Meet St. Jude faculty member Thirumala-Devi Kanneganti, PhD, and learn about her unique path to becoming a leader in the inflammation research field
The renowned clinician and researcher received the St. Baldrick's Foundation Award for Outstanding Achievement in Pediatric Cancer Research.
Dr. Zhang was honored by the International Society for Computational Biology for accelerating research and genomic data sharing.
The Honor Roll
The Nobel Prize is a prestigious award in scientific research due to its recognition of groundbreaking scientific discoveries that have significantly advanced human health and knowledge. Established by Alfred Nobel's will in 1895, it honors individuals whose work has led to profound benefits for humanity. The rigorous selection process, international prestige, and historical legacy of past laureates underscore its importance and symbolize the highest level of achievement in scientific excellence and innovation.
Peter Doherty won the Nobel Prize in Physiology or Medicine in 1996, alongside Rolf Zinkernagel, for their groundbreaking discovery of how the immune system recognizes virus-infected cells. Their research unveiled the concept of MHC restriction, demonstrating that T cells recognize antigens only when presented by the body's own MHC molecules. This discovery significantly advanced the understanding of the immune response and has had profound implications for immunology, vaccine development, and therapeutic strategies against infectious diseases.
Established in 1945, the Lasker Award is a distinguished honor in biomedical research due to its rigorous selection process and history of recognizing pioneering work that has led to major scientific breakthroughs. It acknowledges significant contributions and innovative advancements in medical science that have substantially enhanced the understanding and treatment of major diseases.
Donald Pinkel, MD, received the Lasker Award in 1972 for his groundbreaking work in developing combination chemotherapy for childhood leukemia, which dramatically increased survival rates. His contributions laid the foundation for modern pediatric oncology, transforming leukemia from a nearly fatal disease to a largely treatable condition.
Peter Doherty, PhD, was awarded the Lasker Award in 1995 for his discovery of how the immune system recognizes virus-infected cells, a fundamental insight into immunology. This breakthrough has had significant implications for the development of vaccines and immunotherapies, enhancing our ability to combat infectious diseases and cancer.
The Royal Society is one of the oldest and most respected scientific academies in the world, with a history dating back to the 17th century. Election to the Royal Society signifies recognition of an individual's significant contributions to science, whether through groundbreaking research, influential publications, or other notable achievements in their field. It is considered a mark of distinction and excellence, indicating that the recipient's work has had a profound impact on advancing scientific knowledge and understanding.
Robert Webster, PhD
Fellow, 1989
Peter Doherty, PhD
Fellow, 1996
M. Madan Babu, PhD, FRSC, FMedSci, FRS
Fellow, 2023
Member, National Academy of Sciences
Election to the National Academy of Sciences (NAS) is one of the highest honors bestowed upon a scientist in the United States. It signifies recognition by peers for outstanding contributions to scientific research and innovation. NAS members play a pivotal role in shaping national scientific policy, providing expert advice to government agencies, and advancing scientific knowledge across disciplines. Membership offers unparalleled opportunities for collaboration, networking, and leadership in the scientific community.
Charles Sherr, MD, PhD
Member, 1995
Peter Doherty, PhD
Member, 1998
Robert Webster, PhD
Member, 1998
Brenda Schulman, PhD
Member, 2014
Martine F. Roussel, PhD
Member, 2019
Doug R. Green, PhD
Member, 2020
Being elected to the National Academy of Medicine (NAM) is a prestigious honor in health and medicine. Members are elected by their peers in recognition of their significant contributions to the advancement of medical sciences, healthcare, and related fields. Election to the NAM is based on demonstrated excellence, originality, and impact of the individual's work. Membership in the NAM provides opportunities for collaboration, networking, and furthering the mission of advancing knowledge and providing evidence-based guidance on health-related issues to policymakers and the public.
William Evans, PharmD
Member, 2002
Arthur Nienhuis, MD
Member, 2002
Charles Sherr, MD, PhD
Member, 2004
Peter Doherty, PhD
Member, 2008
Michael Kastan, MD, PhD
Member, 2009
Mary Relling, PharmD
Member, 2009
James R. Downing, MD
Member, 2013
Mitchell Weiss, MD, PhD
Member, 2024
HHMI investigators are distinguished by their exceptional contributions to biomedical research and their potential to make transformative discoveries. They receive significant funding and support from the Howard Hughes Medical Institute, enabling them to pursue their research without the constraints of traditional grant cycles. Moreover, HHMI fosters a collaborative and innovative environment, allowing investigators to exchange ideas and resources freely. This elite status not only validates their work but also provides unparalleled opportunities for scientific exploration and advancement.
James Ihle, PhD
Investigator, 1997
Charles Sherr, MD, PhD
Investigator, 1998
Brenda Schulman, PhD
Investigator, 2005
Michael Dyer, PhD
Investigator, 2013
J. Paul Taylor, MD, PhD
Investigator, 2015
Being elected as a member of the American Academy of Arts and Sciences is a prestigious honor in academia and the arts. It signifies recognition of one's significant contributions to knowledge and culture. It confers a responsibility to uphold the Academy's mission of promoting excellence and addressing societal challenges through research, scholarship, and creative endeavors. As a member, one becomes part of a distinguished community of scholars, scientists, artists, and leaders committed to shaping a better future for society.
Martine F. Roussel, PhD
Fellow and Foreign Honorary Member, 2011
Brenda Schulman, PhD
Member, 2012
Charles Sherr, MD, PhD
Member, 2013
James R. Downing, MD
Member, 2016
Election as a fellow of the American Association for the Advancement of Science (AAAS) is a mark of recognition and distinction in the scientific community. AAAS, one of the world's largest and most prestigious scientific societies, selects members based on their significant contributions to advancing science and its applications for the betterment of society. Membership signifies acknowledgment of one's outstanding research, leadership, and commitment to scientific excellence, while also providing access to a diverse network of peers, opportunities for collaboration, and platforms to further promote science and its impact on society.
Ching-Hon Pui, MD
Fellow, 1998
James R. Downing, MD
Fellow, 2003
Charles Sherr, MD, PhD
Fellow, 2009
Guillermo Oliver, PhD
Fellow, 2011
Charles Rock, PhD
Fellow, 2020
Thirumala-Devi Kanneganti, PhD
Fellow, 2022
Victor J. Torres, PhD
Fellow, 2022
Hongbo Chi, PhD
Fellow, 2023
The AACR Team Science Award is important as it recognizes collaborative efforts that drive significant advances in cancer research. By honoring multidisciplinary teams, the award highlights the power of collective expertise and innovation in tackling complex scientific challenges. This acknowledgment promotes a culture of cooperation and shared knowledge, accelerating progress in understanding cancer and developing effective treatments. It underscores the value of teamwork in achieving breakthroughs that individual efforts alone might not accomplish.
Ching-Hon Pui, MD, won the AACR Team Science Award in 2009 for his leadership in pediatric leukemia research. His team's collaborative efforts have significantly advanced treatment protocols, leading to improved survival rates and outcomes for children with leukemia. This recognition underscores their impactful contributions to cancer research and patient care.
The NCI Outstanding Investigator Award stands as a pinnacle of recognition in cancer research, honoring those whose work has transcended boundaries, reshaping our understanding and approach to cancer. This prestigious award not only celebrates scientific excellence but also embodies a commitment to innovation and perseverance in the face of one of humanity's greatest challenges. Recipients of this award are not only recognized for their past achievements but are also entrusted with substantial funding to continue their groundbreaking work, ensuring a lasting impact on cancer research and treatment.
Douglas R. Green, PhD, was honored with the NCI Outstanding Investigator Award in 2018 for his groundbreaking contributions to cancer biology, particularly in understanding cell death mechanisms, which have significantly advanced cancer research and treatment.
Often called the “Nobel Prize of Alzheimer’s research,” the Potamkin Prize is a prestigious award bestowed on outstanding scientists and researchers who have made significant contributions to the field of neuroscience. Established in 1983 by the Potamkin family, the prize recognizes individuals whose work has advanced our understanding of the brain and its disorders, such as Alzheimer's disease and other neurodegenerative conditions. With a legacy of honoring excellence in neuroscience, the Potamkin Prize highlights the importance of continued innovation and dedication in the pursuit of unraveling the mysteries of the human brain.
In 2020, J. Paul Taylor, MD, PhD, was honored with the prestigious Potamkin Prize for his groundbreaking contributions to the field of neuroscience. Taylor's pioneering research delved into the intricate mechanisms underlying neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). His innovative work not only advanced our understanding of these complex conditions but also offered promising insights into potential therapeutic avenues.
Individuals who receive the American Cancer Society's Medal of Honor are those whose exceptional contributions have significantly advanced the fight against cancer. This prestigious award honors leaders from various fields including research, advocacy, clinical care, and philanthropy, whose efforts have made a profound impact on cancer prevention, treatment, and survivorship. Recipients are celebrated for their extraordinary dedication, innovation, and leadership as they inspire continued progress in the global fight against cancer.
As a distinguished physician-scientist, Ching-Hon Pui, MD, has dedicated his career to advancing the understanding and treatment of childhood cancers, particularly acute lymphoblastic leukemia (ALL). In 2020, Pui’s extraordinary contributions to the field of pediatric oncology were rewarded with the American Cancer Society’s prestigious Medal of Honor. His pioneering research has not only transformed clinical practice but has also significantly improved survival rates and quality of life for pediatric cancer patients worldwide. Dr. Pui's unwavering commitment to excellence, compassion, and innovation has made him a beacon of hope in the fight against childhood cancer, earning him this well-deserved honor.
Being named a Fellow of the Biophysical Society signifies a profound recognition of one's contributions to biophysics. It acknowledges not just scientific excellence but also leadership, service, and impact on the biophysical community. Fellows are distinguished members whose work has advanced our understanding of biological systems at a fundamental level, making them key figures in shaping the future of biophysics and its applications in medicine, biology, and beyond.
Charalampos Kalodimos, PhD, was recognized as a Fellow of the Biophysical Society in 2020 for his exceptional contributions to the field. His research concentrates on understanding the structural dynamics of biomolecules using nuclear magnetic resonance spectroscopy. This prestigious acknowledgment
Presented by the American Society of Pediatric Hematology/Oncology (ASPHO), the Distinguished Career Award is a prestigious honor that recognizes individuals who have made significant and lasting contributions to the field of pediatric hematology/oncology. This award celebrates the recipient's exemplary career achievements, including their leadership, clinical care, research, education, and advocacy efforts that have advanced the care and outcomes for children with hematologic and oncologic disorders.
In 2022, Ching-Hon Pui, MD, was honored with the prestigious ASPHO Distinguished Career Award in recognition of his exceptional contributions to pediatric hematology/oncology. Throughout his illustrious career, Dr. Pui has made groundbreaking advancements in the understanding and treatment of childhood leukemia, particularly acute lymphoblastic leukemia (ALL). His pioneering research has not only improved survival rates but has also enhanced the quality of life for countless pediatric patients worldwide.
The Walter T. Hughes Distinguished Physician Award is an eminent honor presented by the Pediatric Infectious Diseases Society (PIDS). This award recognizes pediatricians with a distinguished career in pediatric infectious diseases and is named in honor of Dr. Walter T. Hughes, a founding member of PIDS and former Chair of Infectious Diseases at St. Jude Children’s Research Hospital. Recipients are esteemed for their dedication to improving the health and well-being of children through the prevention, diagnosis, and treatment of infectious diseases.
Patricia Flynn, MD, was honored with the Walter T. Hughes Distinguished Physician Award in 2023 due to her remarkable contributions to the field of pediatric infectious diseases. As a leader in the field, she has demonstrated unparalleled dedication to improving the health and well-being of children through her innovative approaches to prevention, diagnosis, and treatment of infectious diseases. Flynn's receipt of the Hughes Award recognizes her outstanding achievements and enduring commitment to advancing pediatric infectious diseases medicine, echoing the legacy of her mentor for whom the award is named after.
The Canada Gairdner International Award stands as one of the world's most prestigious awards in biomedical science, recognizing individuals who have made seminal discoveries or contributions to medical science. Award recipients are celebrated for their groundbreaking work, which often leads to significant advancements in understanding and treating disease, highlighting the award's importance in the global scientific community.
In 1981, Wai Yiu (George) Cheung, PhD, was honored with the Canada Gairdner International Award for his discovery of calmodulin. This essential protein plays a crucial role in calcium regulation and is involved in numerous cellular processes. Cheung's work significantly advanced our understanding of molecular biology and has had a lasting impact on various fields, including biochemistry and medicine.
Established by the National Institutes of Health (NIH), the NIH Director’s New Innovator Award is a prestigious grant bestowed upon exceptionally creative early-career scientists who propose innovative approaches to major challenges in biomedical research. This award aims to support groundbreaking research projects that have the potential to transform their respective fields and recipients of the New Innovator Award are selected based on the novelty, potential impact, and feasibility of their proposed research, as well as their track record of innovation and leadership. This highly competitive award provides significant funding and resources to empower awardees to pursue bold and unconventional research ideas, driving forward scientific discovery and innovation.
Charles Gawad, MD, PhD
2018
Lindsay Schwarz, PhD
2019
Chi-Lun Chang, PhD
2022
The New York Academy of Sciences Blavatnik Young Investigator Award is highly prestigious, recognizing early-career scientists who demonstrate exceptional innovation, creativity, and impact in their fields. Winners receive significant recognition and support, empowering them to continue their groundbreaking research and make lasting contributions to science and society.
In 2011, Charalampos Kalodimos, PhD, was named a finalist for the New York Academy of Sciences Blavatnik Young Investigator Award. His innovative work in biophysics, particularly in understanding biomolecular dynamics, distinguished him as a promising young scientist with the potential for significant contributions to the field.
In 2018, Mohan Madan Babu, PhD, FRSC, FMedSci, FRS, was awarded the New York Academy of Sciences Blavatnik Young Investigator Award for his outstanding research in systems biology and bioinformatics. His work has had a profound impact on our understanding of protein interactions and cellular signaling, highlighting his potential as a future leader in the field.
The David A. Karnofsky Memorial Award and Lecture, presented by the American Society of Clinical Oncology (ASCO), is one of the highest honors in the field of oncology. Named after the renowned oncologist David A. Karnofsky, this award recognizes individuals for their outstanding contributions to cancer research, clinical care, and patient advocacy. Recipients of this award are celebrated for their significant impact on advancing the field of oncology and improving cancer care worldwide.
In 1978, Donald Pinkel, MD, received the David A. Karnofsky Memorial Award for his groundbreaking work in pediatric oncology. Pinkel's development of the first successful treatment for childhood leukemia revolutionized the field and dramatically improved survival rates for children with cancer. His receipt of this prestigious award highlighted his pioneering contributions to oncology, particularly in pediatric cancer research and treatment.
Established in 1980 by the Pezcoller Foundation, the Pezcoller Award is a prestigious honor bestowed upon exceptional scientists and researchers who have made significant contributions to cancer research. This award recognizes individuals whose groundbreaking work has advanced our understanding of cancer biology, treatment modalities, and patient care. The Pezcoller Award serves as a beacon for the global scientific community, inspiring continued dedication to the fight against cancer and offering hope for improved outcomes for patients worldwide.
Thanks to his groundbreaking contributions to the field of oncology, Charles Sherr, PhD, was honored with the prestigious Pezcoller Award in 2000. Sherr's pioneering research has significantly advanced our understanding of the molecular mechanisms driving cancer development and progression. Through his relentless dedication and profound insights, Charles Sherr not only transformed our understanding of cancer but also paved the way for novel therapeutic strategies.